Company Filing History:
Years Active: 2024
Title: Sahil Joshi: Innovator in CRISPR Technology
Introduction
Sahil Joshi is a prominent inventor based in Somerville, MA (US). He has made significant contributions to the field of genetic engineering, particularly in the development of CRISPR technology. With a total of 2 patents, his work focuses on enhancing the efficacy of CRISPR complexes.
Latest Patents
Sahil Joshi's latest patents include "Stabilized CRISPR complexes" and "Systems and methods for modulating CRISPR activity." The first patent provides polynucleotides and CRISPR effector proteins that are covalently bound together in a CRISPR complex. This innovation allows for modifications to the polynucleotides, which can improve the efficacy of target binding and cleavage. The second patent outlines polynucleotides designed to bind to CRISPR effector proteins, enabling modulation of their activity through various modifications.
Career Highlights
Sahil Joshi is currently employed at Synthego Corporation, where he continues to advance his research in CRISPR technology. His work is pivotal in the ongoing development of gene editing tools that have the potential to revolutionize medicine and biotechnology.
Collaborations
Some of his notable coworkers include Reed Kelso and Jared Carlson-Stevermer. Their collaborative efforts contribute to the innovative environment at Synthego Corporation.
Conclusion
Sahil Joshi's contributions to CRISPR technology exemplify the impact of innovative thinking in the field of genetic engineering. His patents reflect a commitment to improving the tools available for gene editing, paving the way for future advancements.